vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - la esclerosis múltiple remitente-recurrente - inmunosupresores - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).
vumerity cápsulas gastrorresistentes 231 mg (diroximel fumarato)
biogen chile s.p.a. - diroximel - diroximel fumarato 231,000 mg (1) composición de los comprimidos de diroximel fumarato: núcleo: - vumerity está indicado para el tratamiento de pacientes adultos con esclerosis múltiple remitente recurrente.
dimethyl fumarate mylan
mylan ireland limited - fumarato de dimetilo - la esclerosis múltiple remitente-recurrente - inmunosupresores - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - fumarato de dimetilo - la esclerosis múltiple remitente-recurrente - inmunosupresores - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate teva
teva gmbh - fumarato de dimetilo - multiple sclerosis, relapsing-remitting; multiple sclerosis - inmunosupresores - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - fumarato de dimetilo - multiple sclerosis, relapsing-remitting; multiple sclerosis - inmunosupresores - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - fumarato de dimetilo - la esclerosis múltiple remitente-recurrente - inmunosupresores - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
droximed 500 mg capsulas
medley farmaceutica, s.a. - cefadroxilo - capsulas - 500 mg
digoximed 50mcg/ml solucion oral
albis s.a.c. - solucion oral
droxidel 250 mg/5ml. polvo para suspension oral
laboratorios y droguería pharmadel - polvo para suspensión oral - 250 mg/5ml.